Please login to the form below

Not currently logged in
Email:
Password:

Covid-19

This page shows the latest Covid-19 news and features for those working in and with pharma, biotech and healthcare.

Regeneron’s antibody cocktail prevents COVID-19 in high-risk patients

Regeneron’s antibody cocktail prevents COVID-19 in high-risk patients

The first exploratory analysis of 400 evaluable participants found that passive vaccination with REGEN-COV resulted in 100% prevention of symptomatic COVID-19 infections. ... patients aged at least 12 years old who weigh at least 40kg and are at high

Latest news

More from news
Approximately 310 fully matching, plus 65 partially matching documents found.

Latest Intelligence

  • An EU emergency health fund to limit the impact of future crises An EU emergency health fund to limit the impact of future crises

    The COVID-19 pandemic, and the necessary restrictions and regulations brought in around the world to curb the spread of the virus, has resulted in a global economic crisis. ... risks. The ongoing and unprecedented public health crisis caused by COVID-19

  • The pandemic preparedness paradox The pandemic preparedness paradox

    We must act now. It would be easier to start this work after COVID-19, after we all have our feet under us once again. ... control of COVID-19, the next emergency will draw all attention and sap the collective will.

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    a 10-day dosing regimen of remdesivir administered intravenously versus standard of care in patients with moderate manifestations of COVID-19. ... The European Commission has signed a joint procurement agreement for Gilead’s COVID-19 antiviral

  • 2021: the year of decentralisation in drug development 2021: the year of decentralisation in drug development

    Rising costs and timelines to bring innovative therapies to market – not to mention the COVID-19 pandemic – have accelerated the surge in demand for decentralised clinical trials. ... Adopt agile remote monitoring to keep trials on track. During COVID

  • AstraZeneca’s focus on diagnosing and managing chronic kidney disease AstraZeneca’s focus on diagnosing and managing chronic kidney disease

    In the context of COVID-19, when healthcare systems are strained and we try to protect those with underlying conditions from the direct and indirect impact of the virus, the need

More from intelligence
Approximately 8 fully matching, plus 66 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 62 fully matching, plus 125 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
claire@dovetailstrategies.com

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics